Free Trial
ASX:AFP

AFT Pharmaceuticals (AFP) Stock Price, News & Analysis

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)
Free AFP Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.25%
Price Target
N/A
Stock Analysis
Stock Analysis

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

AFP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive AFP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AFT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:AFP
CUSIP
N/A
CIK
N/A
Web
www.aftpharm.com
Phone
64 9 488 0232
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A$0.09
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$10.92 million
Net Margins
6.26%
Pretax Margin
N/A
Return on Equity
16.51%
Return on Assets
8.53%

Debt

Debt-to-Equity Ratio
55.41
Current Ratio
1.97
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$174.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.70 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
104,870,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.25
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Hartley Atkinson Ph.D.
    Co-Founder, CEO, MD & Executive Director
  • Ms. Marree Atkinson
    Co-Founder, Chief of Staff & Executive Director
  • Mr. Malcolm Tubby B.A.
    BA(Hon's), ICAEW, ICANZ, CFO & Company Secretary
  • Mr. Murray Keith
    Group Marketing Manager
  • Ms. Ioana Stanescu
    Head of Drug Development

Key Competitors

View All Competitors

AFP Stock Analysis - Frequently Asked Questions

How often does AFT Pharmaceuticals pay dividends? What is the dividend yield for AFT Pharmaceuticals?

AFT Pharmaceuticals declared a Final dividend on Wednesday, June 7th. Shareholders of record on Monday, July 3rd will be paid a dividend of 0.007 per share on Monday, July 3rd. This represents a yield of 0.19%. The ex-dividend date is Thursday, June 15th.
Read our dividend analysis for AFP.

Is AFT Pharmaceuticals a good dividend stock?

AFT Pharmaceuticals (ASX:AFP) pays an annual dividend of A$0.01 per share and currently has a dividend yield of 0.25%. The dividend payout ratio is 11.11%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for AFP.

This page (ASX:AFP) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press